These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38338365)

  • 61. X-ray Crystal Structures of the Influenza M2 Proton Channel Drug-Resistant V27A Mutant Bound to a Spiro-Adamantyl Amine Inhibitor Reveal the Mechanism of Adamantane Resistance.
    Thomaston JL; Konstantinidi A; Liu L; Lambrinidis G; Tan J; Caffrey M; Wang J; Degrado WF; Kolocouris A
    Biochemistry; 2020 Feb; 59(4):627-634. PubMed ID: 31894969
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Structure and function of the influenza A M2 proton channel.
    Cady SD; Luo W; Hu F; Hong M
    Biochemistry; 2009 Aug; 48(31):7356-64. PubMed ID: 19601584
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Proton transport through the influenza A M2 channel: three-dimensional reference interaction site model study.
    Phongphanphanee S; Rungrotmongkol T; Yoshida N; Hannongbua S; Hirata F
    J Am Chem Soc; 2010 Jul; 132(28):9782-8. PubMed ID: 20578761
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel.
    Jing X; Ma C; Ohigashi Y; Oliveira FA; Jardetzky TS; Pinto LH; Lamb RA
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10967-72. PubMed ID: 18669647
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Resistance-Mutation (N31) Effects on Drug Orientation and Channel Hydration in Amantadine-Bound Influenza A M2.
    Gleed ML; Ioannidis H; Kolocouris A; Busath DD
    J Phys Chem B; 2015 Sep; 119(35):11548-59. PubMed ID: 26268449
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Drug sensitivity, drug-resistant mutations, and structures of three conductance domains of viral porins.
    Sharma M; Li C; Busath DD; Zhou HX; Cross TA
    Biochim Biophys Acta; 2011 Feb; 1808(2):538-46. PubMed ID: 20655872
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Influenza virus proton channels.
    Pinto LH; Lamb RA
    Photochem Photobiol Sci; 2006 Jun; 5(6):629-32. PubMed ID: 16761092
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Crystal structure of the drug-resistant S31N influenza M2 proton channel.
    Thomaston JL; DeGrado WF
    Protein Sci; 2016 Aug; 25(8):1551-4. PubMed ID: 27082171
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The BM2 protein of influenza B virus interacts with p53 and inhibits its transcriptional and apoptotic activities.
    Zhang H; Yu H; Wang J; Zhang M; Wang X; Ahmad W; Duan M; Guan Z
    Mol Cell Biochem; 2015 May; 403(1-2):187-97. PubMed ID: 25670017
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Design of Broad-Spectrum Inhibitors of Influenza A Virus M2 Proton Channels: A Molecular Modeling Approach.
    Klimochkin YN; Shiryaev VA; Petrov PV; Radchenko EV; Palyulin VA; Zefirov NS
    Curr Comput Aided Drug Des; 2016; 12(2):154-64. PubMed ID: 27146707
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The influenza m2 cytoplasmic tail changes the proton-exchange equilibria and the backbone conformation of the transmembrane histidine residue to facilitate proton conduction.
    Liao SY; Yang Y; Tietze D; Hong M
    J Am Chem Soc; 2015 May; 137(18):6067-77. PubMed ID: 25892574
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Viroporins in the Influenza Virus.
    To J; Torres J
    Cells; 2019 Jun; 8(7):. PubMed ID: 31261944
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Structure and mechanism of the M2 proton channel of influenza A virus.
    Schnell JR; Chou JJ
    Nature; 2008 Jan; 451(7178):591-5. PubMed ID: 18235503
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Design of an Efficient Inhibitor for the Influenza A Virus M2 Ion Channel].
    Vorobjev YN
    Mol Biol (Mosk); 2020; 54(2):321-332. PubMed ID: 32392203
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Insights into binding molecular mechanism of hemagglutinin H3N2 of influenza virus complexed with arbidol and its derivative: A molecular dynamics simulation perspective.
    Boonma T; Soikudrua N; Nutho B; Rungrotmongkol T; Nunthaboot N
    Comput Biol Chem; 2022 Dec; 101():107764. PubMed ID: 36049355
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular origins of asymmetric proton conduction in the influenza M2 channel.
    Lazaridis T
    Biophys J; 2023 Jan; 122(1):90-98. PubMed ID: 36403086
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transport-Relevant Protein Conformational Dynamics and Water Dynamics on Multiple Time Scales in an Archetypal Proton Channel: Insights from Solid-State NMR.
    Mandala VS; Gelenter MD; Hong M
    J Am Chem Soc; 2018 Jan; 140(4):1514-1524. PubMed ID: 29303574
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proton and cation transport activity of the M2 proton channel from influenza A virus.
    Leiding T; Wang J; Martinsson J; DeGrado WF; Arsköld SP
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15409-14. PubMed ID: 20713739
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers.
    Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J
    Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.